Month: July 2021

Nanobodies, or single-domain antibodies, are smaller and simpler than conventional antibodies, but they have huge potential. Since this potential is being explored by multiple research teams, any one team has difficulty producing standout work. Yet researchers from two Göttingen institutions, the Max Planck Institute for Biophysical Chemistry and the University Medical Center, assert that they
0 Comments
A compassionate-use study has generated promising results for the potential treatment of muscular dystrophies using mesenchymal stem cells (MSCs) derived from Wharton’s jelly (WJ), a substance found in the umbilical cord. The study, led by doctors at Klara Medical Center (KMC), Czestochowa, Poland, and reported in STEM CELLS Translational Medicine, found that individuals treated using
0 Comments
Investigators at the Georgetown Lombardi Comprehensive Cancer Center are studying tags or modifications to cell-free DNA (cfDNA) that they believe may lead to a better understanding of how to assess and possibly modulate treatment approaches for cancer and other diseases. Findings from their new analysis were published recently in Frontiers in Genetics through an article entitled
0 Comments
Officials at Cytiva and Pall, part of Danaher, said they will expand manufacturing capacity and services across geographies for global life sciences customers. A $1.5 billion two-year investment, already underway, includes new sites, expansion at existing factories, and is in addition to previously announced investments. It follows five acquisitions made by the companies so far
0 Comments
German health authorities issued WuXi Biologics a License of Manufacturing Permit for its drug product facility (DP7) in Leverkusen, Germany. The six-day inspection was conducted by five inspectors from the Health Authority of Cologne District Government and other regional inspectorates. The scope of the inspections covered not only the areas of cGMP manufacturing required for receiving
0 Comments
Investigators at the University of Washington, department of genome sciences, have uncovered a fascinating genetic aspect of autism. In a newly published study, the researchers identified a rare class of genetic differences transmitted from parents without autism to their affected children with autism and determined that they are most prominent in “multiplex” families with more
0 Comments
The discovery of natural and engineered light-sensitive proteins has developed a versatile and easy-to-use method in neuroscience called optogenetics that uses a light stimulus to precisely regulate neural activity in time and space, and has had an immense impact on understanding neural networks, neuronal function, and signaling pathways. Scientists at the Ruhr-University Bochum, Germany, have
0 Comments
In this 6-lesson online workshop, Nancy Mahoney – Author, teacher and fabric designer – walks you through the fusible appliqué quilting process, shows you how to use machine appliqué on your quilts for a beautiful finish every time. Nancy also shows various quilts, each with their own unique look, achieved by using this one simple
0 Comments
PerkinElmer said today it agreed to acquire BioLegend, a provider of life science antibodies and reagents, for approximately $5.25 billion in cash and stock—the largest acquisition in the buyer’s history—in a deal designed to position PerkinElmer as a leading precision medicine company by accelerating its life-science growth within clinical diagnostics. Based in San Diego, BioLegend
0 Comments